<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01974193</url>
  </required_header>
  <id_info>
    <org_study_id>BFL01</org_study_id>
    <nct_id>NCT01974193</nct_id>
  </id_info>
  <brief_title>Prevention of Pelvic Lymphocele by Floseal During Pelvic Lymphadenectomy for Gynecologic Cancer</brief_title>
  <official_title>Prevention of Pelvic Lymphocele by Floseal During Pelvic Lymphadenectomy for Gynecologic Cancer: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ewha Womans University Mokdong Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Ewha Womans University Mokdong Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pelvic lymph node dissection (PLND) is an important step in the surgical staging and
      treatment of gynecologic malignancies.

      Sometimes, complicated lymphoceles after PLND often delay adjuvant treatment including
      chemotherapy and radiation therapy, which potentially affects the success of cancer
      treatment.

      A number of surgical techniques have developed, but failed to reduce the incidence of pelvic
      lymphoceles after PLND.

      The investigators hypothesized that floseal can prevent lymphoceles in patients with
      gynecologic cancer who has undergone PLND.

      The investigators designed prospective randomized controlled study as a pilot study.

      The investigators will randomly apply floseal to one side of pelvis after bilateral PLND, and
      observe the occurence of pelvic lymphoceles after 6 months later.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of pelvic lymphocele</measure>
    <time_frame>6 month</time_frame>
    <description>Frequency of ipsilateral pelvic lymphocele at post-operative 6th month.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative drainage</measure>
    <time_frame>post-operative 3 days</time_frame>
    <description>left and right post-operative drainage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lymphedema</measure>
    <time_frame>post-operative 3 and 6 month</time_frame>
    <description>lymphedema symptoms and sign at post-operative 3 and 6 month</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Gynecologic Cancer</condition>
  <arm_group>
    <arm_group_label>Floseal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>application of floseal to one side of pelvis after pelvic lymphadenectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>counter-site of pelvis; no intervention after pelvic lymphadenectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Floseal</intervention_name>
    <description>application of floseal on intervention arm</description>
    <arm_group_label>Floseal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gynecologic cancer patients who need laparotomic bilateral PLND

        Exclusion Criteria:

          -  Incomplete PLND which can influence the occurrence of lymphocele (surgeon's decision)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yun Hwan Kim, Dr</last_name>
    <phone>+82-10-9096-7875</phone>
    <email>medok74@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ewha Womans University Mokdong Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>158-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 28, 2013</study_first_submitted>
  <study_first_submitted_qc>October 31, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2013</study_first_posted>
  <last_update_submitted>February 10, 2015</last_update_submitted>
  <last_update_submitted_qc>February 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ewha Womans University Mokdong Hospital</investigator_affiliation>
    <investigator_full_name>Yun Hwan KIM</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphocele</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

